TACTILE SYSTEMS TECHNOLOGY INC
For the period ended May 6, 2026. Filed Mar 25, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 6, 2026 · Filed Mar 25, 2026
Contents
Proxy Summary
The Board of Directors (the “Board of Directors” or “Board”) of Tactile Systems Technology, Inc. (the “Company,” “Tactile Medical,” “we,” “us” or “our”) has made this Proxy Statement and related materials available to you on the internet, or at your request has delivered printed versions to you by mail, in connection with the Board of Directors’ solicitation of proxies for our 2026 Annual Meeting of Stockholders (the “Annual Meeting”). If you requested printed versions of these materials by mail, they will also include a proxy card for the Annual Meeting.
This summary highlights information contained elsewhere in this Proxy Statement. It does not contain all of the information you should consider, and we urge you to read the entire Proxy Statement, as well as our 2025 Annual Report to Stockholders, before voting.
Date, Time and Place of the Annual Meeting
| | | | |
|---|---|---|---|
| Date and TimeMay 6, 20269:00 a.m., Central time | LocationWells Fargo CenterSuite 2200, 90 South Seventh StreetMinneapolis, MN 55402 | Record DateMarch 12, 2026 | Mail DateMarch 25, 2026 |
Items of Business to be Considered at the Annual Meeting
| | | |
|---|---|---|
| Voting Matters | | Board Recommendation |
| | | |
| To elect nine directors | | FOR each Nominee |
| | | |
| To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2026 | | FOR |
| | | |
| To approve, on an advisory basis, the 2025 compensation of our named executive officers | | FOR |
| | | |
| Approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to provide that directors may be removed in a manner consistent with Delaware law | | FOR |
| | | |
| | |
|---|---|
| 2026 Proxy Statement | 5 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.